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Resveratrol, a stilbenic compound deriving from the phenyalanine/polymalonate route, being stilbene synthase the last and key
enzyme of this pathway, recently has become the focus of a number of studies in medicine and plant physiology. Increased demand
for this molecule for nutraceutical, cosmetic and possibly pharmaceutic uses, makes its production a necessity. In this context, the
use of biotechnology through recombinant microorganisms and plants is particularly promising. Interesting results can indeed
arise from the potential of genetically modiﬁed microorganisms as an alternative mechanism for producing resveratrol. Strategies
used to tailoring yeast as they do not possess the genes that encode for the resveratrol pathway, will be described. On the other
hand,mostinteresthascenteredinrecentyears,onSTSgenetransferexperimentsfromvariousoriginstothegenomeofnumerous
plants. This work also presents a comprehensive review on plant molecular engineering with the STS gene, resulting in disease
resistance against microorganisms and the enhancement of the antioxidant activities of several fruits in transgenic lines.
1.Introduction
Hydroxystilbenes (hereafter referred to as stilbenes) are nat-
ural phenolic compounds occurring in a number of plant
families including Vitaceae, Dipterocarpaceae, Gnetaceae,
Pinaceae, Poaceae, Fabaceae, Leguminoseae, and Cyperaceae
[1]. Although polyphenolic compounds display an enor-
mous chemical diversity, stilbenes seem to constitute a rather
restricted group of molecules, the skeleton of which is based
on resveratrol especially in Vitaceae and Fabaceae (Figure 1)
[2]. Resveratrol is one of the most extensively studied natural
products, doubtless for its large spectrum of biological
activities in human health as a cardioprotective, an anti-
tumor, a neuroprotective, and an antioxidant agent. Some
of the resveratrol’s properties have been associated with the
beneﬁts of a moderate consumption of red wine. Many roles
have also been ascribed to resveratrol and its derivatives
(Figure 1) in plants; namely, they constitute antimicrobial,
deterrent or repellent compounds acting as allelochemicals
or phytoalexins, protecting them from attacks by fungi,
bacteria, nematodes, or herbivores [3–5].
According to these potential activities in plants and
humans, the interest for resveratrol has increased. Cur-
rently, rising demand for resveratrol and derivatives for
nutraceutical, cosmetic, and putatively pharmaceutical uses
makes their production a necessity. Metabolic engineering
for resveratrol production thus has signiﬁcant commercial
value. As all the genes encoding enzymes responsible for
resveratrol biosynthesis have been cloned and characterized
indetail,thismakesmolecularengineeringofthiscompound
relatively straightforward.
Mostinteresthasnowcentereduponmetabolicengineer-
ing of resveratrol in plants with the objectives of increasing
tolerance of the latter to pathogenic microorganisms and2 Journal of Biomedicine and Biotechnology
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Figure 1: Molecular structures of trans-a n dcis-resveratrol 1 and 3, and trans-a n dcis-piceid, 2 and 4, respectively (GlcO = β-D-glucose).
improving the nutritional quality of food products through
the expression of pharmaceutically active compounds in
plants incapable of synthesizing resveratrol.
Microorganisms can also be used to heterologously
express the resveratrol biosynthetic pathway to obtain this
compoundinvaluableamounts.Inthispaper,wewilldiscuss
the potential of tailored microorganisms, speciﬁcally yeast,
and plants for resveratrol production.
2. Resveratrol inHealth andDisease
Resveratrol was identiﬁed in 1940 as a constitutive com-
pound of the roots of white hellebore (Veratrum grandi-
ﬂorum)[ 6]. Resveratrol is also present in high amounts
in the roots of Polygonum cuspidatum used in traditional
Chinese and Japanese medicine, and this compound was
acclaimed for its wondrous eﬀects for the treatment of
human fungal diseases (suppurative dermatitis, gonorrhea
favus, and athlete’s foot), hyperlipidemia, atherosclerosis,
or inﬂammations. Moreover, resveratrol recently has been
shown to be a potent therapeutic agent [7–10].
First, there is considerable evidence that resveratrol acts
both as a free radical scavenger [11, 12]a n dap o t e n t
antioxidant doubtless for its ability to promote the activities
of numerous antioxidative enzymes [12, 13]. Resveratrol
inhibits lipid peroxidation which is an indicator of possible
free radical damage to cellular membranes [14, 15]. Resver-
atrol may operate in a number of antioxidant mechanisms
leading to the development of atherosclerosis, protecting,
for example, LDL molecules against peroxidation [16–18]o r
reactive oxygen species production by blood platelets [19].
Thereishoweversomeevidencethatresveratrolexhibitspro-
oxidant activity under certain experimental conditions (in
the presence of copper ions) [20], causing oxidative DNA
damage that may lead to cell cycle arrest or apoptosis [21].
Resveratrolisalsoconsideredasanantiproliferativeagent
for cancer [22], exerting an antitumor activity either as a
cytostatic or as a cytotoxic agent in various types of cancer.
Resveratrol induces cell death through positive induction
of death receptor-mediated apoptosis [23–25], mitchondria-
mediated apotosis [26], and nuclear (transcription) factor-
mediated apotosis [27, 28].
Refractory disease and poor prognosis in many tumors
have been related with high expression of antiapoptotic
molecules such as survivin; resveratrol was proven to act
at this level through survivin depletion [29]. Similarly,
numerousworksshowedthatresveratrolisapotentinhibitor
of cell cycle progression, causing G1 phase arrest [30],
inhibiting G0-G1 transition in human lymphocyte [31]o r
perturbing progression through S and G2 phases in cultured
bovine artery endothelial cell proliferation [32]. Since the
pioneering work of the group of Pezzuto [33], aﬀording for
the very ﬁrst time evidence for the cancer chemoprotective
activity of resveratrol on HL-60 and Hepa 1clc7 cells, many
other models of human cancers were used, conﬁrming these
ﬁndings. The most frequently described mode of action
for resveratrol concerns apoptosis (see above), the response
depending on the expression of the tumor suppressor gene
p53. A number of related factors can be modulated by
resveratrol, such as activation of caspases, decreases in the
antiapoptotic proteins Bcl-2 and Bcl-xL [34, 35], increases
in the proapoptotic proteins Bax [36], inhibition of cyclins
and cyclin-dependent kinases, that is, proteins implicated in
cell cycle progression [32, 37], and interference with nuclear
transcriptionfactorkappaB(NF-κB)—andactivatorprotein
1 (AP-1)—mediated cascades.
Most importantly, there are several works concerning
both the antitumor eﬀects and the antitumor mechanisms of
resveratrol in vivo. In several studies, it was shown, namely,
that resveratrol inhibits the development of skin cancer in
vivo by topical applications, causing a signiﬁcant reduction
of the tumor diameter and the tumor incidence [33, 38,
39]. Moreover, resveratrol signiﬁcantly inhibits the UV-B-
mediated increase in skin thickness and skin edema [40]. On
theotherhand,resveratrolwasprovennottobeveryeﬀective
in inhibiting the progression of leukemia in vivo, even when
high doses were used [41], despite its antileukemic activity in
vitro and though resveratrol can be converted to the known
antileukemic related stilbene, piceatannol [42]. In regard to
breast cancer, resveratrol was shown to reduce N-methyl-
N-nitrosourea-induced mammary tumorigenesis in female
rats at high doses (100mg/kgbodyweight) though being
uneﬀective at lower doses (10mg/kg body weight) [43]. Oth-
erwise, some authors have shown that resveratrol glucosides,
namely, piceid (a 3-O-β-D-resveratrol glucoside), admin-
istered orally or intraperitoneally to mice, reduced tumor
volume, tumor weight, and metastasis in lung carcinoma
[44, 45]. A few investigations about the antitumor eﬀectsJournal of Biomedicine and Biotechnology 3
of resveratrol and derivatives against liver cancers have been
reported to date, showing that this compound administered
orally or intraperitoneally to rats caused a 25% reduction in
tumor cell numbers and restrained hepatoma cell invasion
but not proliferation [46, 47]. Finally, orally administration
of resveratrol to mice was shown to prevent colonic tumor
formation and reduce small intestinal tumors by 70% [48].
Neurologic beneﬁts of resveratrol described experimen-
tally concern the following diseases: cerebral ischemia in
rats [49, 50], amyotrophic lateral sclerosis [51], Parkinson’s
disease in rats [52], spinal cord lesions in rabbits [53],
brain edema and tumors in human cells [54], seizure in
rats [55–57], pain and cognitive impairment in rats [58,
59]. According to Dor´ e[ 60], the neuroprotective eﬀects of
resveratrol could be mediated by regulation of the heme
oxygenase antioxidant systems in neurons, especially in case
of age-related vascular dementia and Alzheimer’s disease
[61].
T h e r ea r es e v e r a lm e c h a n i s m st os u p p o r tr e s v e r a t r o la s
a cardioprotective agent such as inhibition of LDL perox-
idation, reduction of the degree of neointimal hyperplasia
and restenosis, inhibition of platelet aggregation together
with chemoprevention of atherosclerogenesis. Resveratrol
was proven to inhibit LDL peroxidation via antioxidant and
free scavenging activities in ex vivo rat heart studies [62]
and circumstantial evidence of its potent role in preventing
atherosclerogenesis could thus be given [63, 64]. Resveratrol
was shown to inhibit neointimal hyperplasia in several
animal studies and vascular smooth muscle cell proliferation
in a rabbit model of restenosis [65, 66] and to block platelet
aggregation from high-cholesterol-fed rabbits [67].
Resveratrol exerts some activities against a range of
bacteria aﬀecting humans (Chlamydia pneumonia, the cause
of human acute respiratory tract infections [68], and
Helicobacter pylori, the main agent responsible for chronic
gastritis and peptic ulcer disease [69, 70]). Resveratrol also
inhibited the growth of several bacteria known to be major
agents of human skin infections such as Staphylococcus
aureus, Enterococcus faecalis,a n dPseudomonas aeruginosa
[71]. Similarly, resveratrol completely inhibits the growth of
Neisseria gonorrhoeae (responsible for the sexually transmit-
ted disease gonorrhoea) [72]. Stilbenes generally also have
biocidal activities against plant fungal pathogens (namely,
Botrytis cinerea, the causal organism for gray mold, Pyricu-
laria oryzae, the agent of pyriculariosis, Plasmopara viticola,
the causal agent for downy mildew [73–77], fungi associated
with esca of grapevine [78]), and human fungal pathogens
such as Candida albicans, an agent of candidiasis [79].
Finally, resveratrol has been shown to extend the lifespan
of lower organisms, yeast [80], and metazoans [81], via the
sirtuin/Sir2 family. More recently, a study has conﬁrmed the
conservation of these preventive and protective mechanisms
controlling lifespan extension in higher organisms such as
mice [82]. Using a similar approach, other works reached
the same conclusions with regard to the protective eﬀects
of resveratrol against diet-induced obesity and insulin resis-
tance [7, 82].
Otherwise, DNA-damaging products can induce prema-
ture senescence in cancer cells, limiting tumor development.
However, senescent cancer cells may reenter the cell cycle
andleadtotumorrelapse.Recently,resveratrolwasremarked
by its ability to induce DNA damage in cancer cells. In
fact, resveratrol suppressed viability and induced DNA
damage in human head and neck squamous carcinoma cells
[83]. Similarly, human squamous cancer cells treated with
resveratrol were shown to express oxidative stress-mediated
DNA damage [84].
3. Biosynthesis of Resveratrol
Stilbene phytoalexins, as ﬂavonoid-type phytoalexins, are
formed on the phenylalanine/polymalonate route, being the
last step of this biosynthesis pathway catalyzed by stilbene
synthase (STS) (Figure 2). Trans-resveratrol can be synthe-
sized either starting with phenylalanine or from tyrosine,
both pathways giving rise to para-coumaric acid through,
respectively, the phenylalanine ammonia lyase (PAL) and
the cinnamate 4 hydroxylase (C4H), or directly through the
tyrosine ammonia lyase (TAL). A para-coumaric-acid coen-
zyme A ligase (4CL) transforms the para-coumaric acid into
para-coumaroyl-CoA, which then leads to trans-resveratrol
after condensation with three molecules of malonyl-CoA
through STS activity [85]. STS belongs to the so-called type
III of the polyketide synthase enzyme superfamily, a class
of enzymes which carry out iterative condensation reactions
with malonyl-CoA. [86, 87]. Resveratrol synthesis is induced
inplantsasaresponsetofungalinfection[73,74,88],abiotic
stresses (UV irradiation, metallic salts, methyl jasmonate)
[89–93] as well as to natural compounds eliciting plant
defense responses [94, 95] or nonpathogenic rhizobacteria
[96, 97].
STS is encoded by a multigene family mainly comprising
the resveratrol-forming STS genes from grapevine (pSV21,
pSV25, pSV696, pSV368,a n dStSy)[ 98], (Vst1, Vst2, Vst3)
[99], the AhRS gene from Arachis hypogea [100], and an
STS-encoding gene from Parthenocissus henryana [101].
Other STS genes have also been isolated from pine [102–
104], together with a stilbene synthase gene from Vitis
riparia cv Gloire de Montpellier [105]. The Sb STS1 gene
isolated from Sorghum is at present the only one STS gene
described in a Monocotyledonous plant [106]. Knowledge
of the resveratrol biosynthetic route thus paves the way for
metabolic engineering in microorganisms or plants.
4. Tailoring Yeast for Resveratrol Biosynthesis
Microorganisms are widely used biological systems whose
engineering may be useful for the production of numerous
valuable molecules and can lead to interesting applications
for example in the wine industry [107–109]. Engineering
bacteria or yeast for resveratrol might thus represent a
valuable means of its production in large quantities. Their
tailoringisnecessarybecausemicroorganismsdonotpossess
the genes that encode for the resveratrol pathway. In this
paper, we will focus only on yeast tailoring for resveratrol
production. Two main strategies have already been used to
that end: (i) introducing the entire biosynthetic pathway4 Journal of Biomedicine and Biotechnology
O
O
O
O
O O
O
OH
SCOA
SCOA
TAL 
STS 
4CL 
C4H 
PAL 
+ 
Shikimate pathway
HO
HO
HO
HO
HO
OH OH
OH
OH
OH
Phenylalanine
Cinnamic acid
Para-coumaric acid
Para-coumaroyl-CoA
Trans-resveratrol
NH2
NH2 H
Tyrosine
3 malonyl–CoA
Figure 2: Biosynthesis of resveratrol via the phenylalanine/polymalonate pathway. PAL, phenylalanine ammonia lyase; TAL, tyrosine
ammonia lyase; C4H, cinnamate-4-hydroxylase; 4CL, para-coumaric acid: coenzyme A ligase; STS, stilbene synthase.
using aromatic amino acids as substrates (L-phenylalanine
or L-tyrosine) [110–113] and (ii) introducing speciﬁc genes,
such as para-coumaroyl-CoA ligase and stilbene synthase,
starting with para-coumaric acid as a substrate (Figure 2)
[114–120].
4.1. Engineering the Entire Pathway. To obtain resveratrol
from its precursors L-phenylalanine or L-tyrosine on the
phenylpropanoid route appears to be the most promising
option in terms of production cost. The entire resveratrol
pathway has been introduced successfully into the oleagi-
nous yeast Yarrowia lipolytica (ATCC 20362 strain) with
the genes encoding for phenylalanine/tyrosine ammonia
lyase (PAL/TAL), cinnamate-4-hydroxylase (4CH), para-
coumaroyl-CoA ligase (4CL), and stilbene synthase (STS)
activities [110]( Table 1). Metabolic engineering was com-
pletedbyconstitutiveexpressionofmalonylCoA,aprecursor
for both naringenin-chalcone, the ﬁrst C15 intermediate
in the ﬂavonoid route, and stilbene synthesis. Genes that
encode for each requiredenzyme from diﬀerentplantspecies
(grapevine, peanuts) have been tested. In the best perform-
ing yeast, genes that encode for the PAL and TAL from
Rhodotorula glutinis, the 4CL from Streptomyces coelicolor,
and an STS from Vitis sp. have been used, and the resulting
production of resveratrol reached in this system 1.46mg/L
[110].
Current eﬀorts to increase resveratrol bioproduction in
yeast have focused, so far not surprisingly, on heterologous
expression of the genes encoding for the enzymes involved
in the phenylpropanoid pathway and for STS, in baker
yeast Saccharomyces cerevisiae [111, 113–120]. Namely, the
entire resveratrol pathway has been introduced in S. cere-
visiae (CEN.PK113-5D strain), but also in molds such as
Aspergillus niger (FGSC A913 strain) and A. oryzae (MG1363
strain). In these cases, pathway expression started with the
PAL enzyme. The ability of tailored S. cerevisiae to produce
resveratrol was characterized, but it was not synthesized in
measurable amounts in this system. [111]. More recently,Journal of Biomedicine and Biotechnology 5
Table 1: Metabolic engineering of resveratrol in yeast.
Microorganisms/species Introduced gene(s) Origin of genes Resveratrol
quantity References
Yeast Yarrowia lipolytica PAL/TAL, C4H, 4CL,
STS
Rhodotorula glutinis (PAL/TAL), Streptomyces
coelicolor (4CL), Vitis sp. (STS) 1.46mg/L [110]
Yeast Saccharomyces cerevisiae PAL, C4H, 4CL, STS Arabidopsis thaliana (PAL, C4H, 4CL), Rheum
tataricum (STS) not detectable [111]
Yeast Saccharomyces cerevisiae TAL, 4CL::STS fusion
protein
Rhodobacter sphaeroides (TAL), Arabidopsis
thaliana (4CL), Vitis vinifera (STS) 5.25mg/L [116]
Yeast Saccharomyces cerevisiae 4CL, STS Populus trichocarpa×Populus deltoides (4CL),
Vitis vinifera (STS) 1.45mg/L [114]
Yeast Saccharomyces cerevisiae 4CL, STS Nicotiana tabacum (4CL), Vitis vinifera (STS)5 . 8 m g / L [ 115]
Yeast Saccharomyces cerevisiae 4CL1, STS Arabidopsis thaliana (4CL), Vitis vinifera (STS) 262–391mg/L [117]
Yeast Saccharomyces cerevisiae
with phenylalanine
PAL, CPR, C4H, 4CL,
STS
Populus trichocarpa×P. deltoides (PAL, CPRa)
Glycine max (C4H, 4CL), Vitis vinifera (STS) 0.29mg/L [113]
Yeast Saccharomyces cerevisiae
with para-coumaric acid
PAL, CPR, C4H, 4CL,
STS
Populus trichocarpa×P. deltoides (PAL, CPR)
Glycine max (C4H, 4CL), Vitis vinifera (STS) 0.31mg/L [113]
Yeast Saccharomyces cerevisiae
TAL, 4CL::STS fusion
protein, araE
transporter
Rhodobacter sphaeroides (TAL), Escherichia coli
(araE), Arabidopsis thaliana (4CL), Vitis
vinifera (STS)
3.1mg/L1.27mg/L
(without the araE
transporter)
[119]
Yeast Saccharomyces cerevisiae TAL, 4CL::STS fusion
protein
Rhodobacter sphaeroides (TAL), Arabidopsis
thaliana (4CL), Vitis vinifera (STS) 14.4mg/L [120]
aCPR: Cytochrome P450 Reductase.
Trantas et al. [113] constructed the complete resveratrol
biosynthetic pathway in S. cerevisiae to produce resveratrol
from phenylalanine. When the medium was supplemented
with 10mM of phenylalanine, the strain produced 0.29mg/L
trans-resveratrol after about 120h of cultivation. One can
thus admit that the introduction of the complete resveratrol
pathway in yeast leads to a low production of this compound
when compared to some other data obtained in engineered
bacteria where resveratrol synthesis can reach up to 100–
170mg/L [121, 122].
4.2. Introducing Selective Genes. An alternative strategy to
engineering the entire pathway is directed towards trans-
forming microorganisms with selective genes [114–120]
(Table 1).TheyeaststrainS.cerevisiaeFY23wastransformed
with both the 4CL and STS genes under utilization of
para-coumaric acid as a precursor (added to the culture
medium). However, in this system, resveratrol production
remained low (1.45mg/L) [114]. Interestingly, in another
study, authors reported that transformation of S. cerevisiae
(CEN.PK113-3b strain) with the 4CL gene from tobacco
and the STS gene from grapevine enabled it to produce
resveratrol in higher quantities (5.8mg/L) [115]. A S.
cerevisiae (WAT11 strain) cotransformed with 4CL and STS
constructs and fed with para-coumaric acid only produced
0.65mg/L resveratrol, but, when the 4CL and the STS-
encoding genes that were added to the yeast genome were
submittedtoproteinfusion,yeastexpressing4CL::STSfusion
proteinexhibiteda10-foldincreaseinresveratrolproduction
(5.25mg/L resveratrol) compared to the coexpression of
4CL and STS [116]. This underlines the importance of the
spatial localization of these two related enzymes [116]. In
another study of the same group [120], authors have utilized
a synthetic scaﬀold to recruit the 4CL1 and STS enzymes of
the resveratrol pathway to improve resveratrol production
in S. cerevisiae. A 5-fold improvement of the resveratrol
production was obtained over the nonscaﬀolded control,
and a 2.7-fold increase (14.4mg/L within 96h incubation)
was ﬁnally observed over the previous reported study with
p r o t e i nf u s i o n[ 116]. This work clearly demonstrated that
synthetic scaﬀolds can be used for the optimization of
engineered metabolic pathway.
Most importantly, it has recently been shown that yeast
cells expressing 4CL, STS genes together with the araE gene
encoding for a high-capacity Escherichia coli transporter,
b u tw i t hn oa ﬃnity for resveratrol itself, could enhance
resveratrol accumulation. Yeast cells carrying the araE gene
produced up to 3.1mg/L, that is, 2.44-fold higher resveratrol
than the control cells [119]. Such an engineered yeast was
alsoproventoincreasetheresveratrolcontentinawhitewine
during the fermentation process [119].
It should be noted that the eﬃcacy of recombinant
microorganisms for resveratrol production depends on
various factors, such as the species and the strain, the origin
of the transferred genes, culture conditions as well as other
parameters such as plasmids or precursors used (Table 1).
Ar e c e n ts t u d y[ 117] has shown that fermenting yeast
expressing the para-coumaroyl-coenzyme A ligase (4CL1)
from Arabidopsis thaliana and the stilbene synthase from
Vitis vinifera in a rich medium could considerably improve
resveratrol production, rising from a few milligrams per
liter to 262mg/L in rich medium using a laboratory strain.6 Journal of Biomedicine and Biotechnology
Moreover,resveratrolamountsreachedupto391mg/Lwhen
fermentation was achieved with an industrial Brazilian sugar
cane yeast [117].
Taken together, these data indicate that the levels of
resveratrol that can be produced by microorganisms remain
low, although optimization of the processes might be
possible.
5. Tailoring Plants for Resveratrol Biosynthesis
Asresveratrolisapotentphytoalexinagainstplantpathogens
and can enhance plant resistance to microbial disease, earlier
applications of resveratrol engineering focused primarily on
this antimicrobial potential [123, 124]. Tailoring plants for
resveratrolsynthesisthusconstitutesthesecondaspectofthis
paper. Particular attention will be given in this section to the
choice of the promoters and the enhancer elements used to
improve STS transcriptional activity in the transgenes as well
as the biological beneﬁts of resveratrol production in terms
ofenhancementofantioxidantactivityinfruitsandlegumes.
We have seen that tailoring yeast needs the introduction
of the entire resveratrol pathway (requiring at least 4 or
5 genes) or the introduction of selective genes (requir-
ing at least 2 genes) depending on the precursor used,
phenylalanine or para-coumaric acid. Tailoring plants for
resveratrol synthesis appear to be very simple, since STS is
a key enzyme of resveratrol synthesis utilizing as substrates
precursor molecules that are present throughout the plant
kingdom. The introduction of a single gene is thus suﬃcient
to synthesize resveratrol in heterologous plant species. A
lot of transformations were then operated to investigate the
potentialofstilbenebiosyntheticgenestoconferresistanceto
pathogens or to increase their nutritional values [123, 124].
5.1. Production of Resveratrol in Transgenic Plants: Gene and
Promoter Options. The ﬁrst gene transfer experiment was
performed by the group of Kindl with a complete STS gene
from Arachis hypogea introduced into tobacco [100], leading
to resveratrol accumulation in response to short-wavelength
ultraviolet light. This experiment was then continued by the
same group by the transfer of two grapevine STS genes,
Vst1 and Vst2, in tobacco, conferring to the plant a higher
resistance to Botrytis cinerea infection. This work constitutes
the ﬁrst report of a disease resistance resulting from foreign
phytoalexin expression in a novel plant [125]. Since this
pioneering work, STS genes have been transferred to a
number of plants, including rice [126], barley and wheat
[127–130], alfalfa [131], kiwifruit [132], grapevine [133,
134] apple [135, 136], aspen [137], papaya [138], white
poplar [139], oilseed rape [140], banana [141], Rehmannia
[142]tomato[143–147],Arabidopsis [148],lettuce[101],pea
[149], and hop [150]( Table 2).
In grapevine, genome sequencing has revealed a large
array of STS genes, with 43 genes identiﬁed and 20
of these being shown to be expressed [151]. But to date,
only a few STS genes from grapevine are used for the
metabolic engineering of plants, being Vst1 and Stsy the
most commonly genes chosen (Table 2). STS-encoding genes
from other plants have also been used, notably the AhRS
gene from Arachis hypogea [100, 131], the SbSTS1 gene
from Sorghum bicolor [106, 148], and an STS-encoding gene
from Parthenocissus henryana [101]. Chimeric genes or a
combination of two STS encoding genes, based on Vst1 and
Vst2, can increase signiﬁcantly resveratrol production in the
transformed lines [128, 152].
On a practical point of view, the modulation of gene
expression is mainly controlled by the promoter chosen to
drive the transgene. By now, a limited number of promoters
(the constitutive promoter pCaMV35S, its own stress-
responsive promoter pVst1, the fungus-inducible promoter
pPR10.1 or the tissue speciﬁc promoter p-nap) have been
used for the expression of STS-encoding genes upon plant
transformation(Table 2 andreferencestherein).Asexpected,
the pCaMV35S promoter, which is the most commonly used
to overexpress a transgene in plants [152], triggered strong
andconstitutivestilbeneaccumulation(Table 2).Inthiscase,
stilbene synthesis is higher than that observed with inducible
promoters, but, as a consequence, causes a drastic depletion
of the endogenous pools of precursors. In grapevine, the
pVst1 promoter which is induced either by biotic factors
(pathogens, elicitors) or abiotic stresses (wounding, UV
light), allows high stilbene production without interfering
with secondary biosynthetic pathways. Generally, it appears
thus preferable to transform plants with a construct having a
pathogen-inducible promoter in order to avoid depletion of
other pathways.
Expression of the STS gene may be optimized by the uti-
lizationofenhancerelements[127,130]and/orheterologous
promoters[131–135,140,152]toimproveSTStranscription.
Combination of the pVst1 promoter with the 35S enhancer
element [127, 130] or use of a chimeric promoter resulting,
for example, from a fusion between the alfalfa pPR10.1
promoter and the pVst1 promoter can lead to higher
expression of the transgene without aﬀecting promoter
inducibility or speciﬁc expression patterns [127], or to an
increased production of resveratrol upon fungal infection
(reaching5–100-foldthelevelsfoundinnontransgenicleaves
[133]). Finally, tissue-speciﬁc promoters such as the p-nap
seed-speciﬁc napin promoter can be used to induce stilbene
production [140].
At this stage of the discussion, it appears important to
underline that the choice of the promoter for STS gene
expression should be performed depending on the expected
results: when the enhancement of plant resistance against
pathogens through resveratrol production is searched, thus
one can recommend the choice of a strong constitutive
promoter or a pathogen-inducible promoter (see above). As
far as may concern this review, when the improvement of
food products is sought through, for example the increase of
the antioxidant activity of the transformed plants, a tissue-
speciﬁc [140, 147] or inducible promoter would be a better
option.
STS genes were transferred to plants by means of
Agrobacterium spp. in tomato [143], grapevine [133],
kiwifruits [132] or particle bombardment in barley and
wheat [127–129]. However, as epigenetic modiﬁcations may
occurandleadtoexpressionvariability,decreasingtheabilityJournal of Biomedicine and Biotechnology 7
Table 2:Metabolicengineeringofstilbenesynthaseinplants,andresultingeﬀectsonstilbenelevels,resistancetopathogens,andantioxidant
activities.
Plant/species Introduced gene(s) Promoter Produced
stilbene(s)
Stilbene
quantity (mg/kg
of FW)
Biological
activity References
Tobacco (Nicotiana
tabacum L.)
Arachis hypogea STS Stress-induced
promoter Resveratrol — — [100]
Grapevine Vst1 and Vst2 Stress responsive
pVst1 Resveratrol 400 Resistance to
Botrytis cinerea [125]
Chimeric STS gene Constitutive
CaMV 35S Resveratrol 50 to 290
Altered ﬂower
morphology,
male sterility
[152]
Rice (O r y z as a t i v aL . ) Grapevine Vst1 Stress responsive
pVst1 ——
Resistance to
Pyricularia
oryzae ?
[126]
Wheat (Triticum
aestivum L.)
Grapevine Vst1
Combination
pVst1 +35S
enhancer
—— Resistance to
Botrytis cinerea [127, 129]
Chimeric STS gene Maize ubiquitin
promoter Resveratrol 2 — [128]
Grapevine Vst1 and Vst2
Combination
pVst1 +35S
enhancer
Unknown
derivative stilbene
compounds
35 to 190
Resistance to
Puccinia
recondita and
Septoria
nodorum
[130]
Barley (Hordeum
vulgare L.) Grapevine Vst1
Combination
pVst1 +35S
enhancer
—— Resistance to
Botrytis cinerea [127]
Alfalfa (Medicago sativa
L.)
Arachis hypogea STS
gene (AhRS)
Constitutive
CaMV 35S Piceid 0.5 to 20
Resistance to
Phoma
medicaginis
[131]
Arabidopsis thaliana L. Sorghum SbSTS1 Constitutive
CaMV 35S Piceid 584 — [106, 148]
Kiwi (Actinidia
deliciosa) pSV25 Constitutive
CaMV 35S Piceid 20 to 182 No resistance to
Botrytis cinerea [132]
Grapevine (Vitis
vinifera L.)
Grapevine Vst1 Fungus inducible
ms PR 10.1 Resveratrol
In vitro
resistance to
Botrytis cinerea
[133]
Vitis pseudoreticulata
STS
Constitutive
CaMV 35S Resveratrol 2.586 Not determined [134]
Apple (Malus
domestica)
Grapevine Vst1 Stress responsive
pVst1
Unknown
resveratrol-
glycoside
—— [ 135]
Grapevine Vst1 Stress responsive
pVst1 Piceid
3t o7f o rn o n -
UV-irradiated
fruit and 23 to
62 for
UV-irradiated
fruit
No inﬂuence on
other phenolic
compounds
[136]
Tomato (Lycopersicon
esculentum Mill.)
Grapevine Vst1 and Vst2 Stress responsive
pVst1 Resveratrol —
Resistance to
Phytophthora
infestans No
resistance to
Botrytis cinerea
and Alternaria
solani
[143]
Grapevine StSy Constitutive
pCaMV 35S
Resveratrol and
piceid 4t o5 3
Antioxidant
primary
metabolism and
increase in total
antioxidant
activity
[144]8 Journal of Biomedicine and Biotechnology
Table 2: Continued.
Plant/species Introduced gene(s) Promoter Produced
stilbene(s)
Stilbene
quantity (mg/kg
of FW)
Biological
activity References
Grapevine StSy Constitutive
pCaMV 35S
Resveratrol and
piceid 0.1 to 1.2
Enhancement of
natural
antiradical
properties
[145]
Grapevine StSy Constitutive
pCaMV 35S
Resveratrol and
piceid
0.42 to 126
depending on
the stage of
ripening and
fruit samples
Diﬀerences in
rutin,
naringenin, and
chlorogenic acid
contents
[146]
Grapevine StSy
Fruit-speciﬁc
promoter
TomLoxB
Resveratrol and
piceid
Increases in
total antioxidant
capability and
ascorbic acid
content
[147]
Rehmannia glutinosa
Libosch. Arachis hypogea AhRS3 Constitutive
pCaMV 35S
Resveratrol and
piceid
22 to 116 up to
650 with stress
treatment
Antioxidant
capabilities
Resistance to
Fusarium
oxysporum
[142]
Lettuce (Lactuca sativa
L.)
Parthenocissus
henryanaSTS
Constitutive
pCaMV 35S Resveratrol 56.4 Eﬀect on Hela
cell morphology [101]
Pea (Pisum. sativum L.) Grapevine Vst1 Stress responsive
pVst1
Occurrence of two
resveratrol-
glucoside
compounds
0.53 to 5.2 — [149]
White poplar (Populus
alba L.) Grapevine StSy Constitutive
pCaMV 35S Piceid 309 to 615
No in vitro
resistance to
Melampsora
pulcherrima
[137, 139]
Papaya (Carica papaya
L.) Grapevine Vst1 Stress responsive
pVst1
Resveratrol
glucoside 54
Resistance to
Phytophthora
palmivora
[138]
Oilseed rape (Brassica
napus L.) Grapevine Vst1 Tissue speciﬁc
p-nap
Resveratrol
glucoside 361 to 616
Food quality
improvement:
high piceid rate
content and
reduction of
sinapate esters
[140]
Hop (Humulus lupulus
L.) Grapevine Vst1 Constitutive
pCaMV 35S
Piceid, unknown
stilbene astringin,
resveratrol
490 to 560
Higher amounts
of ﬂavonoids
and acids
[150]
ofthetransgenesforstilbenesynthesis,theselectionofplants
with a single gene insertion will be more appropriate. As a
consequence, the use of Agrobacterium-mediated transfor-
mation, which leads to lower transgene insertion numbers,
should preferentially be chosen [124].
5.2. Stilbene Production and Biological Beneﬁts of Resveratrol
Synthesis in STS Engineered Plants. Expression of STS genes
resulted in resveratrol accumulation in transgenic lines. The
obtained stilbene amounts are generally higher than those
reached in engineered yeast, ranging from a few mg/kg fresh
weight to hundreds of mg/kg fresh weight (see Table 2). Both
freeresveratrolanditsglycosylatedformscanberecoveredin
p l a n te x t r a c t s[ 144]: piceid, a 3-O-β-D-resveratrol glucoside,
occurred in diﬀerent plant species transformed with STS
genes (Table 2)[ 106, 132, 136, 139, 140, 142, 145, 146, 148,
150]. However, levels of accumulated stilbenes depend on
the plant species (probably because of diﬀerent endogenous
pools of enzymes or precursors, as well as diﬀerences
in secondary metabolism pathways), the promoter used
(constitutive or inducible promoters), the ripening stage in
case of transgenic fruits [136, 144] and the age of the organs
[125, 132].
From a practical viewpoint, the ectopic production of
resv eratr olobserv edintransformedplantscanleadtobr oad-
spectrum resistance against fungi in transgenic plants, butJournal of Biomedicine and Biotechnology 9
disparateeﬀectswereobserved(Table 2).Someworksindeed
reported transformations improving the resistance of rice to
Pyricularia oryzae [126], tomato to Phytophthora infestans
[143], barley and wheat to B. cinerea [127, 129], wheat to
Oidiumtuckeri[127,129],alfalfatoPhomamedicaginis[131]
and papaya to Phytophthora palmivora [138]. Conversely, in
some others, no resistance was observed after transforming
the plants with stilbene synthase genes. For example, trans-
formation of white poplar (Populus alba)w i t hSTS, leading
to the accumulation of piceid, does not confer any increased
resistance to rust disease (Melaspora pulcherrima)[ 137, 139].
Similarly, no increased resistance against B. cinerea has been
observed in STS transgenic kiwi plants [132].
With regard to the improvement of the nutritional value
of agricultural crops and fruits, there are already several
studies reporting an increase of the antioxidant activities
in transgenic tomatoes and apples overexpressing STS-
encoding genes [136, 144, 147]. In tomato, for example,
resveratrol accumulation in transgenic fruit increased their
global antioxidant activities, as well as their contents in
other well-known antioxidants such as ascorbic acid and
glutathione [144]. Antioxidant activity, as a consequence
of resveratrol accumulation, was also shown to suﬀer a
two-fold increase in transgenic tomato fruit versus controls
[145]. Moreover, a correlation was found between resver-
atrol concentrations and antioxidant activities in ripe and
unripe fruits [145]. More recently [147], tomato plants
expressing a stilbene synthase gene (StSy) under the control
of a fruit-speciﬁc promoter (promoter TomLoxB) were
shown to accumulate resveratrol and piceid in the skin
of the mature fruits, being the resveratrol content of the
plants transformed with the speciﬁc promoter TomLoxB
20-fold lower than that of plants previously transformed
with the constitutive pCaMV35S promoter [144]. However,
both the total antioxidant capability and the ascorbic acid
content were increased in the transformed fruits. These
results explain the higher capability of transgenic fruits to
counteract the proinﬂammatory eﬀects of phorbol ester in
monocyte–macrophages via the inhibition of induced cyclo-
oxygenase-2 enzyme [147]. This last example constitutes a
nice illustration of what can be expected from molecular
engineering of resveratrol in plants in terms of improvement
of the nutritional value of fruits or food products.
6. Conclusions
Increased demand for resveratrol for nutraceutical, cosmetic
and possibly pharmaceutic uses makes its production from
sustainable sourcing a necessity. In this context, the use
of biotechnology through recombinant microorganisms and
plants is particularly promising [5, 112, 118]. Interesting
results can indeed arise from the potential of genetically
modiﬁed microorganisms as an alternative mechanism for
producing resveratrol, as this compound can be synthesized
directly in recombinant yeast (the subject of the present
review) but also in bacteria, such as Escherichia coli [112,
118]. Use of recombinant bacteria or yeast is of interest
for the food industry, which could produce resveratrol in
large quantities in biofermentators. Tailoring yeast can also
receive direct applications in winemaking, as for example,
fermentation engineering to produce resveratrol in wine (or
to increase the wine resveratrol content) [119]. Otherwise,
a transgenic yeast expressing a gene for a glycosyl hydrolase
capable of liberating free resveratrol from its glucoside
f o r mh a sb e e nr e p o r t e da sw e l lt oi n c r e a s er e s v e r a t r o l
amounts in wine [153] or the wine-related antioxidant
content [114]. Beside the fact that disease resistance can
be obtained following expression of STS-encoding genes,
molecular engineering of plants with resveratrol may also
lead to food products comprising edible legumes, cereals,
or fruits, which can be ingested with their potential clinical
beneﬁts, by humans. Taken together, these results suggest the
overall relevance of metabolic engineering of resveratrol.
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